UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 153.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 399,534 shares of the construction company's stock after purchasing an additional 241,741 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.49% of Aspen Aerogels worth $11,063,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Point72 Hong Kong Ltd purchased a new position in Aspen Aerogels during the second quarter valued at $84,000. nVerses Capital LLC purchased a new position in Aspen Aerogels during the 2nd quarter valued at about $95,000. Quent Capital LLC bought a new stake in Aspen Aerogels during the third quarter worth about $118,000. Point72 DIFC Ltd purchased a new stake in Aspen Aerogels in the second quarter worth about $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new position in shares of Aspen Aerogels during the second quarter valued at approximately $145,000. 97.64% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the firm's stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares in the company, valued at $14,523,709.20. This trade represents a 11.58 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 4.30% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the company. Barclays reduced their price objective on Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a research report on Tuesday, November 12th. Piper Sandler reduced their price target on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a report on Tuesday, October 22nd. HC Wainwright reiterated a "buy" rating and set a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a research note on Wednesday, November 13th. Finally, TD Cowen increased their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the company a "buy" rating in a research report on Tuesday, August 20th. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $28.70.
Read Our Latest Stock Report on ASPN
Aspen Aerogels Price Performance
Shares of NYSE:ASPN traded down $0.12 during trading on Friday, hitting $13.36. 1,742,438 shares of the company's stock were exchanged, compared to its average volume of 2,642,037. The business's 50-day simple moving average is $18.60 and its 200 day simple moving average is $23.47. The company has a market cap of $1.10 billion, a price-to-earnings ratio of 1,336.00 and a beta of 2.11. Aspen Aerogels, Inc. has a 52-week low of $10.75 and a 52-week high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.
Aspen Aerogels Company Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Further Reading
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.